Gordagen Pharmaceuticals: R&D tax boost for Gordagen ahead of US nutraceutical launch
Australian nutraceutical firm Gordagen Pharmaceuticals is preparing to launch its heart health and endurance products in the US by the end of the year.
Read full article »
Gordagen Pharmaceuticals developing novel supplements for inflammatory diseases and cardiovascular disease.
Read more